![]() |
|
![]() |
|
Systematic (IUPAC) name | |
---|---|
5-Butyl-5-ethyl-1,3-diazinane-2,4,6-trione
|
|
Clinical data | |
Trade names | Soneryl |
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral |
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
CAS Registry Number | 77-28-1 ![]() |
ATC code | N05CA03 |
PubChem | CID: 6473 |
DrugBank | DB01353 ![]() |
ChemSpider | 6229 ![]() |
UNII | OHZ8QAW6YC ![]() |
KEGG | D02618 ![]() |
ChEMBL | CHEMBL404422 ![]() |
Chemical data | |
Formula | C10H16N2O3 |
Molecular mass | 212.246 g/mol |
|
|
|
|
![]() |
Butobarbital (BAN), also called butobarbitone or butethal, Soneryl, and Neonal,[1] is a hypnotic drug which is a barbiturate derivative. It was developed by Poulenc Brothers (now part of Rhône Poulenc) in 1921.[2]
References
- ^ International Drug Names
- ^ DE Patent 481129
|